| 1 |
Controlled Hybrid-Assembly of HPV16/18 L1 Bi VLPs in Vitro |
|
|
| Shi Jin, Dong-Dong Zheng, Bo Sun, Xianghui Yu, Xiao Zha, Yongjiang Liu, Shuming Wu, Yuqing Wu |
|
| ACS Applied Materials & Interfaces. 2016; 8(50): 34244 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Conjugation of HPV16 E7 to cholera toxin enhances the HPV-specific T-cell recall responses to pulsed dendritic cells in vitro in women with cervical dysplasia |
|
|
| Nurkkala, M., Wassén, L., Nordström, I., Gustavsson, I., Slavica, L., Josefsson, A., Eriksson, K. |
|
| Vaccine. 2010; 28(36): 5828-5836 |
|
| [Pubmed] [Google Scholar] |
|
| 3 |
Conjugation of HPV16 E7 to cholera toxin enhances the HPV-specific T-cell recall responses to pulsed dendritic cells in vitro in women with cervical dysplasia |
|
|
| Merja Nurkkala,Lotta Wassén,Inger Nordström,Inger Gustavsson,Lucija Slavica,Agnetha Josefsson,Kristina Eriksson |
|
| Vaccine. 2010; 28(36): 5828 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Human papillomavirus vaccination: what is the best choice? A comparison of 16 strategies by means of a decisional model |
|
|
| R. GASPARINI,D. AMICIZIA,P. MANFREDI,F. ANSALDI,C. LUCIONI,G. GALLELLI,D. PANATTO |
|
| Epidemiology and Infection. 2009; 137(06): 794 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Human papillomavirus vaccination: what is the best choice? A comparison of 16 strategies by means of a decisional model |
|
|
| GASPARINI, R. and AMICIZIA, D. and MANFREDI, P. and ANSALDI, F. and LUCIONI, C. and GALLELLI, G. and PANATTO, D. |
|
| Epidemiology and Infection. 2009; 137(6): 794-802 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Different spectra of therapeutic vaccine development against HPV infections |
|
|
| Bolhassani, A., Mohit, E., Rafati, S. |
|
| Human Vaccines. 2009; 5(10): 671-689 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Vaccines for human papillomavirus infection: A critical analysis |
|
|
| Thappa, D.M., Nath, A.K. |
|
| Indian Journal of Dermatology, Venereology and Leprology. 2009; 75(3): 245-254 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Alphavirus-adjuvanted norovirus-like particle vaccines: Heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge |
|
|
| LoBue, A.D., Thompson, J.M., Lindesmith, L., Johnston, R.E., Baric, R.S. |
|
| Journal of Virology. 2009; 83(7): 3212-3227 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Alphavirus-Adjuvanted Norovirus-Like Particle Vaccines: Heterologous, Humoral, and Mucosal Immune Responses Protect against Murine Norovirus Challenge |
|
|
| Anna D. LoBue, Joseph M. Thompson, Lisa Lindesmith, Robert E. Johnston, Ralph S. Baric |
|
| Journal of Virology. 2009; 83(7): 3212 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
DNA vaccination and gene therapy: optimization and delivery for cancer therapy |
|
|
| Angela M Bodles-Brakhop,Ruxandra Draghia-Akli |
|
| Expert Review of Vaccines. 2008; 7(7): 1085 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Development of Unilateral Cervical and Supraclavicular Lymphadenopathy After Human Papilloma Virus Vaccination |
|
|
| James Studdiford,Kathleen Lamb,Kedron Horvath,Marc Altshuler,Amber Stonehouse |
|
| Pharmacotherapy. 2008; 28(9): 1194 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
DNA vaccination and gene therapy: Optimization and delivery for cancer therapy |
|
|
| Bodles-Brakhop, A.M., Draghia-Akli, R. |
|
| Expert Review of Vaccines. 2008; 7(7): 1085-1101 |
|
| [Pubmed] [Google Scholar] |
|
| 13 |
Development of Unilateral Cervical and Supraclavicular Lymphadenopathy After Human Papilloma Virus Vaccination |
|
|
| Studdiford, J. and Lamb, K. and Horvath, K. and Altshuler, M. and Stonehouse, A. |
|
| Pharmacotherapy. 2008; 28(9): 1194-1197 |
|
| [Pubmed] [Google Scholar] |
|
